Evidence map›Paper›PMID 34547592›Full record

ReviewCurrent opinion in chemical biology2021

Structure-based protein design with deep learning.

Sergey Ovchinnikov, Po-Ssu Huang

Abstract readReview
In one paragraph

Review in Current opinion in chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. De Novo-Designed Bifunctional Proteins for Targeted Protein Degradation.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Exploring the Blueprint of Life: The Innovation in Antibody and Protein Design.Combinatorial chemistry & high throughput screening · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. ESM-scan-A tool to guide amino acid substitutions.Protein science : a publication of the Protein Society · 2024
    Article
  13. Protein subcellular localization prediction tools.Computational and structural biotechnology journal · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Fast, accurate ranking of engineered proteins by target-binding propensity using structure modeling.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  19. The structural landscape of the immunoglobulin fold by large-scale de novo design.Protein science : a publication of the Protein Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sergey OvchinnikovJohn Harvard Distinguished Science Fellowship Program, Harvard University, Cambridge, MA, 02138, USA. Electronic address: so@fas.harvard.edu.
Po-Ssu HuangDepartment of Bioengineering, Stanford University, Stanford, CA, 94305, USA. Electronic address: possu@stanford.edu.

Funding

Exploring the unknown protein universe using evolutionary informationDP5OD026389 · OD · HARVARD UNIVERSITY · PI OVCHINNIKOV, SERGEY L. · 2018 to 2022
$2.0M
NIH HHS DP5 OD026389
6 · The paper itself

Abstract

Since the first revelation of proteins functioning as macromolecular machines through their three dimensional structures, researchers have been intrigued by the marvelous ways the biochemical processes are carried out by proteins. The aspiration to understand protein structures has fueled extensive efforts across different scientific disciplines. In recent years, it has been demonstrated that proteins with new functionality or shapes can be designed via structure-based modeling methods, and the design strategies have combined all available information - but largely piece-by-piece - from sequence derived statistics to the detailed atomic-level modeling of chemical interactions. Despite the significant progress, incorporating data-derived approaches through the use of deep learning methods can be a game changer. In this review, we summarize current progress, compare the arc of developing the deep learning approaches with the conventional methods, and describe the motivation and concepts behind current strategies that may lead to potential future opportunities.

Indexed as

Deep LearningProteinsProteinsDeep learningNeural networksProtein designProtein sequence designProtein structureProtein structure design

Identifiers

PMID34547592
PMCPMC8671290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.